U.S. FDA Changes COVID-19 Vaccination Authorizations

In COVID-19, Latest News by Precision Vaccinations

The U.S. Food and Drug Administration (FDA) announced various actions to expand the use of COVID-19 vaccines in eligible populations.
The FDA amended the emergency use authorizations (EUA) for FDA Authorized or Approved COVID-19 vaccines to allow for the heterologous (“mix and match”) use of a single booster dose.
And the FDA confirmed the increased risks of inflammatory heart conditions for younger men following mRNA vaccination.
The highlight changes are as follows:

Read More